Stroke remains a leading cause of death and disability, with limited therapeutic options and
suboptimal tools for diagnosis and prognosis. High throughput technologies such as …

While neurovascular diseases such as ischemic and hemorrhagic stroke are the leading
causes of disability in the world, the repertoire of therapeutic interventions has remained …

Stroke is the second leading cause of death worldwide and the third leading cause of death
in the USA. A clinically useful biomarker for the diagnosis of stroke does not currently exist …

Stroke is one of the most common causes of death worldwide and a major cause of acquired
disability in adults. Despite advances in research during the last decade, prevention and …

Stroke has a high incidence rate and often leads to permanent disability, particularly if it is
not treated promptly. However, no blood biomarkers for early diagnosis are available to …

Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Neuroproteomics, an emerging field at the intersection of neuroscience and proteomics, has
garnered significant attention in the context of neurotrauma research. Neuroproteomics …

Hemorrhagic stroke (HS) is a significant cause of mortality that requires rapid diagnosis and
prompt medical attention. A time-efficient diagnostic test to assist in the early classification of …

Although stroke is among the most common causes of death and chronic disability
worldwide, the proteome of the ischemic human brain remains unknown. Only a few studies …

Objective: Mechanical retrieval of thrombotic material from acute ischemic stroke patients
provides a unique entry point for translational research investigations. Here, we resolved the …